Skip to content
Skip to navigation menu

 
Homepage Image 1

Welcome

Welcome to the Cardiff School of Pharmacy and Pharmaceutical Sciences.


The School of Pharmacy and Pharmaceutical Sciences is one of twenty six UK schools of pharmacy and the only one in Wales.


Welcome from the Head of School

 

 

Students working in a Pharmacy.

Undergraduate Programme

The Masters in Pharmacy is consistently ranked as one of the best in the U.K. and is fully approved.


Pharmacy PG Seminar

Postgraduate programmes 

Supervised research study leading to Doctoral degrees , as well as a range of taught postgraduate courses.


PhD students Monerah Al Soraj and Catherine Watkins together with ATJ analysing drug delivery systems in leukaemia cells using the new confocal microscopy facility at WSOP.

Research

Research in the Cardiff School of Pharmacy and Pharmaceutical Sciences has been organised around four research disciplines. 

Highlight Publications

Co-operative membrane disruption between cell penetrating peptide and cargo - implications for the therapeutic use of the Bcl-2 converter peptide D-NuBCP-9-r8.

Watkins, C.L., Sayers, E.J., Allender, C., Barrow, D., Fegan, C., Brennan, P., Jones, A.T. 

Molecular Therapy DOI:10.1038/mt.2011.175 (2011).

Low temperature fabrication of biodegradable sugar glass microneedles for transdermal drug delivery applications.

Martin CJ, Allender CR , Brain KR, Morrissey A and Birchall JC. 

Journal of Controlled Release DOI:10.1016/j.jconrel.2011.10.024 (2011).

Phosphoramidate ProTides of the Anticancer Agent FUDR Successfully Deliver the Preformed Bioactive Monophosphate in Cells and Confer Advantage over the Parent Nucleoside.

 Christopher McGuigan , Paola Murziani, Magdalena Slusarczyk, Blanka Gonczy, Johan Vande Voorde, Sandra Liekens, and Jan Balzarini 

J. Med. Chem. 2011, 54, 7247–7258.

Small Molecule Inhibitors of Retinoic Acid 4-Hydroxylase (CYP26): Synthesis and Biological Evaluation of Imidazole Methyl 3-(4-(aryl-2-ylamino)phenyl)propanoates.

Gomaa, M. S.; Bridgens, C. E.; Aboraia, A. S.; Veal, G. J.; Redfern, C. P.; Brancale, A. ; Armstrong, J. L.; Simons, C  

J Med Chem 2011, 54 (8), 2778-91.

Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression. 

Gruden, M. A., Sewell R. D. E. , Yanamandra, K., Davidova, T. V. Kucheryanu, V. G., Bocharov E. V., Bocharova O. R., Polyschuk, V.V., Sherstnev V.V.,. Morozova-Roche L. A.

Neuroimmunol (2011) 233, 221-227. doi:10.1016/j.jneuroim.2010.12.001

 

Wales Centre for Pharmacy Professional Education